» Articles » PMID: 34827292

Potential Role of Vitamins A, B, C, D and E in TB Treatment and Prevention: A Narrative Review

Abstract

(1) Background: Tuberculosis (TB) is one of the world's top infectious killers, in fact every year 10 million people fall ill with TB and 1.5 million people die from TB. Vitamins have an important role in vital functions, due to their anti-oxidant, pro-oxidant, anti-inflammatory effects and to metabolic functions. The aim of this review is to discuss and summarize the evidence and still open questions regarding vitamin supplementation as a prophylactic measure in those who are at high risk of (MTB) infection and active TB; (2) Methods: We conducted a search on PubMed, Scopus, Google Scholar, EMBASE, Cochrane Library and WHO websites starting from March 1950 to September 2021, in order to identify articles discussing the role of Vitamins A, B, C, D and E and Tuberculosis; (3) Results: Supplementation with multiple micronutrients (including zinc) rather than vitamin A alone may be more beneficial in TB. The WHO recommend Pyridoxine (vitamin B6) when high-dose isoniazid is administered. High concentrations of vitamin C sterilize drug-susceptible, MDR and extensively drug-resistant MTB cultures and prevent the emergence of drug persisters; Vitamin D suppresses the replication of mycobacterium in vitro while VE showed a promising role in TB management as a result of its connection with oxidative balance; (4) Conclusions: Our review suggests and encourages the use of vitamins in TB patients. In fact, their use may improve outcomes by helping both nutritionally and by interacting directly and/or indirectly with MTB. Several and more comprehensive trials are needed to reinforce these suggestions.

Citing Articles

Nutritional Factors and Food and Nutrition Insecurity in Patients with Tuberculosis.

Mendes Y, Dourado A, de Oliveira P, Rezende A, Sales A, de Sousa G Nutrients. 2025; 17(5).

PMID: 40077748 PMC: 11901461. DOI: 10.3390/nu17050878.


Hypercoagulability in Tuberculosis: Pathophysiological Mechanisms, Associated Risks, and Advances in Management-A Narrative Review.

Mitroi D, Balteanu M, Cioboata R, Vlasceanu S, Zlatian O, Catana O J Clin Med. 2025; 14(3).

PMID: 39941433 PMC: 11818899. DOI: 10.3390/jcm14030762.


Vitamin C and Tuberculosis: Examining the Relationship Between Antioxidant Defense and Disease Severity-Preliminary Findings from a Southwestern Romanian Study.

Cioboata R, Nicolosu D, Balasoiu A, Balteanu M, Zlatian O, Osman A J Clin Med. 2024; 13(22).

PMID: 39597859 PMC: 11594612. DOI: 10.3390/jcm13226715.


Synergistic Power of Piceatannol and/or Vitamin D in Bleomycin-Induced Pulmonary Fibrosis In Vivo: A Preliminary Study.

Ezz Eldeen N, Moustafa Y, Alwaili M, Alrehaili A, Khodeer D Biomedicines. 2023; 11(10).

PMID: 37893021 PMC: 10604873. DOI: 10.3390/biomedicines11102647.


The dawn of repurposing vitamins as potential novel antimicrobial agents: A call for global emergency response amidst AMR crisis.

Max B, Angolile C, Raymond V, Mashauri H Health Sci Rep. 2023; 6(5):e1276.

PMID: 37216052 PMC: 10199457. DOI: 10.1002/hsr2.1276.


References
1.
Rekha R, Muvva S, Wan M, Raqib R, Bergman P, Brighenti S . Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in human macrophages. Autophagy. 2015; 11(9):1688-99. PMC: 4590658. DOI: 10.1080/15548627.2015.1075110. View

2.
He W, Hu S, Du X, Wen Q, Zhong X, Zhou X . Vitamin B5 Reduces Bacterial Growth Regulating Innate Immunity and Adaptive Immunity in Mice Infected with . Front Immunol. 2018; 9:365. PMC: 5834509. DOI: 10.3389/fimmu.2018.00365. View

3.
Hanekom W, Potgieter S, Hughes E, Malan H, Kessow G, Hussey G . Vitamin A status and therapy in childhood pulmonary tuberculosis. J Pediatr. 1998; 131(6):925-7. DOI: 10.1016/s0022-3476(97)70046-5. View

4.
Brighenti S, Bergman P, Martineau A . Vitamin D and tuberculosis: where next?. J Intern Med. 2018; . DOI: 10.1111/joim.12777. View

5.
Mugusi F, Rusizoka O, Habib N, Fawzi W . Vitamin A status of patients presenting with pulmonary tuberculosis and asymptomatic HIV-infected individuals, Dar es Salaam, Tanzania. Int J Tuberc Lung Dis. 2003; 7(8):804-7. View